1. The interplay between microRNAs and Twist1 transcription factor: a systematic review
   Hashem Khanbabaei et al, 2016, Tumor Biol. CrossRef
2. MiR-285 targets P450 (CYP6N23) to regulate pyrethroid resistance in Culex pipiens pallens
   Mengmeng Tian et al, 2016, Parasitol Res CrossRef
3. Expression and Significance of Circulating MicroRNA-31 in Lung Cancer Patients
   Wei Gu, 2015, Med Sci Monit CrossRef
4. Nanoformulation-based sequential combination cancer therapy
   Gayong Shim et al, 2017, Advanced Drug Delivery Reviews CrossRef
5. Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs
   Sayan Mullick Chowdhury et al, 2016, Journal of Controlled Release CrossRef
6. MicroRNA-21 versus microRNA-34: Lung cancer promoting and inhibitory microRNAs analysed in silico and in vitro and their clinical impact
   Meik Kunz et al, 2017, Tumour Biol. CrossRef
7. The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies
   David D.W. Twa et al, 2017, Blood Reviews CrossRef
8. Evaluation of plasma microRNA levels to predict insensitivity of patients with advanced lung adenocarcinomas to pemetrexed and platinum
   Jinghua Zhu et al, 2016 CrossRef
9. Inherent and toxicant-provoked reduction in DNA repair capacity: A key mechanism for personalized risk assessment, cancer prevention and intervention, and response to therapy
   Bernd Kaina et al, 2018, International Journal of Hygiene and Environmental Health CrossRef
10. Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-art
    Weronika Maria Szejniuk et al, 2018, Pharmacogenomics J CrossRef
11. Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier
    Martina Da Ros et al, 2018, IJMS CrossRef
12. MicroRNA-mediated redox regulation modulates therapy resistance in cancer cells: clinical perspectives
    Safieh Ebrahimi et al, 2019, Cell Oncol. CrossRef
13. Interactive functions of microRNAs in the miR‐23a‐27a‐24‐2 cluster and the potential for targeted therapy in cancer
    Mengying Cui et al, 2019, J Cell Physiol CrossRef
14. Conditioned medium of primary lung cancer cells induces EMT in A549 lung cancer cell line by TGF-ß1 and miRNA21 cooperation
    Rosa Camerlingo et al, 2019, PLoS ONE CrossRef
15. MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy
    A.-M. Yu et al, 2016, Drug Metabolism and Disposition CrossRef
16. ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview
    Elena Arrigoni et al, 2016, Expert Opinion on Drug Metabolism & Toxicology CrossRef
17. MicroRNAs as key mediators of hepatic detoxification
    Yemiao Chen et al, 2016, Toxicology CrossRef
18. Micro RNA Molecules as Modulators of Treatment Resistance, Immune Checkpoints Controllers and Sensitive Biomarkers in Glioblastoma Multiforme
    Marek Mazurek et al, 2020, IJMS CrossRef
19. MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas
    Irina Fadejeva et al, 2017, Oncotarget CrossRef
20. A microRNA profile of pediatric glioblastoma: The role of NUCKS1 upregulation
    Laura Giunti et al, 2019, mol clin onc CrossRef
21. Crosstalk between noncoding RNAs and ferroptosis: new dawn for overcoming cancer progression
    Xuefei Zhang et al, 2020, Cell Death Dis CrossRef
22. Revisiting cancer hallmarks: insights from the interplay between oxidative stress and non-coding RNAs
    Li Zhou et al, 2020, Mol Biomed CrossRef
23. Circ_0000079 Decoys the RNA-Binding Protein FXR1 to Interrupt Formation of the FXR1/PRCKI Complex and Decline Their Mediated Cell Invasion and Drug Resistance in NSCLC
    Chen Chen et al, 2020, Cell Transplant CrossRef
24. Role of SOX Protein Groups F and H in Lung Cancer Progression
    Mateusz Olbromski et al, 2020, Cancers CrossRef
25. miR-21 Induces Chemoresistance in Ovarian Cancer Cells via Mediating the Expression and Interaction of CD44v6 and P-gp
    Yanqing Wang et al, 2021, OTT CrossRef
26. Down-Regulating the Expression of miRNA-21 Inhibits the Glucose Metabolism of A549/DDP Cells and Promotes Cell Death Through the PI3K/AKT/mTOR/HIF-1α Pathway
    Ye Sun et al, 2021, Front. Oncol. CrossRef
27. Drug penetration through the blood–brain barrier after radiotherapy: New approaches to bypass glioblastoma chemoresistance
    Iacopo Sardi et al, 2021 CrossRef
28. Honokiol combined with curcumin sensitizes multidrug‑resistant human lung adenocarcinoma A549/DDP cells to cisplatin
    Mingming Qi et al, 2021, Exp Ther Med CrossRef
29. microRNAs in cancer chemoresistance: The sword and the shield
    Priya Mondal et al, 2021, Non-coding RNA Research CrossRef
30. Regulation of drug transporters by microRNA and implications in disease treatment
    Yoon-Jee Chae et al, 2022, J. Pharm. Investig. CrossRef
31. Positive regulation of ataxia-telangiectasia-mutated protein (ATM) by E2F transcription Factor 1 (E2F-1) in cisplatin-resistant nasopharyngeal carcinoma cells
    Zun-Yan Zhou et al, 2022, World J Surg Onc CrossRef
32. Design, synthesis, and biological evaluation of novel 7-substituted 10,11-methylenedioxy-camptothecin derivatives against drug-resistant small-cell lung cancer in vitro and in vivo
    Guorui Zhang et al, 2022, European Journal of Medicinal Chemistry CrossRef
33. Downregulation of miR-21 as a promising strategy to overcome drug resistance in cancer
    Tara Akhtarkhavari et al, 2022, European Journal of Pharmacology CrossRef
34. From Molecular Mechanisms to Therapeutics: Understanding MicroRNA-21 in Cancer
    Jiho Rhim et al, 2022, Cells CrossRef
35. Adipose Tissue-Derived Extracellular Vesicles Contribute to Phenotypic Plasticity of Prostate Cancer Cells
    Allison Mathiesen et al, 2023, IJMS CrossRef
36. Emerging role of non-coding RNAs in resistance to platinum-based anti-cancer agents in lung cancer
    Priya Mondal et al, 2023, Front. Pharmacol. CrossRef
37. Engineered Biosensors for Diagnosing Multidrug Resistance in Microbial and Malignant Cells
    Niharika G. Jha et al, 2023, Biosensors CrossRef
38. Emerging role of miRNAs in the regulation of ferroptosis
    Reza Mahmoudi-Lamouki et al, 2023, Front. Mol. Biosci. CrossRef
39. Noncoding RNAs in cancer ferroptosis: From biology to clinical opportunity
    Chan Shan et al, 2023, Biomedicine & Pharmacotherapy CrossRef
40. Gamma Knife Radiosurgery Modulates micro-RNA Levels in Patients with Brain Metastasis
    Imran Khan et al, 2023, CRP CrossRef
41. Composition of Conditioned Media from Radioresistant and Chemoresistant Cancer Cells Reveals miRNA and Other Secretory Factors Implicated in the Development of Resistance
    Daria Molodtsova et al, 2023, IJMS CrossRef
42. Exploring the Therapeutic Potential of Quercetin in Cancer Treatment: Targeting Long Non-Coding RNAs
    Farhad Sheikhnia et al, 2024, Pathology - Research and Practice CrossRef
43. MiR-21-5p knockdown inhibits epithelial to mesenchymal transition in A549 lung adenocarcinoma cells by upregulating RhoB
    Hiba Hussein A. Khair et al, 2024, Mol Biol Rep CrossRef
44. miRNA-21, an OncomiR that regulates cell proliferation, migration, invasion and therapy response in lung cancer
    Roberta Queiroz da Silvia Lima et al, 2024, Pathology - Research and Practice CrossRef
45. A Critical Review on microRNAs as Prognostic Biomarkers in Laryngeal Carcinoma
    Kristina S. Komitova et al, 2024, IJMS CrossRef
46. MiRNAs: main players of cancer drug resistance target ABC transporters
    Forogh Mohammadi et al, 2025, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef